scholarly journals A national cancer plan for the UK

2000 ◽  
Vol 11 (12) ◽  
pp. 1511-1512 ◽  
Author(s):  
D.J. Kerr
Keyword(s):  
National Cancer Plan ◽  
Cancer Plan ◽  
The Uk

scholarly journals 039 Regional disparities in cancer survival following the NHS National Cancer Plan for England: an analysis by cancer network

2010 ◽  
Vol 64 (Suppl 1) ◽  
pp. A16-A16
Author(s):  
S. Walters ◽  
M. Quaresma ◽  
B. Rachet ◽  
D. Forman ◽  
E. Gordon ◽  
...  
Keyword(s):  
Cancer Survival ◽  
Regional Disparities ◽  
National Cancer Plan ◽  
Cancer Plan ◽  
Cancer Network

Does the UK really have an effective cancer plan?

2007 ◽  
Vol 8 (9) ◽  
pp. 747 ◽  
Author(s):  
The Lancet Oncology
Keyword(s):  
Cancer Plan ◽  
The Uk

scholarly journals Resection rate of lung cancer in Teesside (UK) and Varese (Italy): a comparison after implementation of the National Cancer Plan

Thorax ◽  
2015 ◽  
Vol 71 (3) ◽  
pp. 230-237 ◽  
Author(s):  
Andrea Imperatori ◽  
Richard N Harrison ◽  
Lorenzo Dominioni ◽  
Neil Leitch ◽  
Elisa Nardecchia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
National Cancer Plan ◽  
Resection Rate ◽  
Cancer Plan

scholarly journals A Head and Neck 'Two-Week Wait' Clinic: Cancer Referrals or the Worried Well ?

2012 ◽  
Vol 94 (6) ◽  
pp. 1-4 ◽  
Author(s):  
J Rimmer ◽  
J Watson ◽  
P O'Flynn ◽  
F Vaz
Keyword(s):  
Head And Neck Cancer ◽  
Early Detection ◽  
Head And Neck ◽  
Neck Cancer ◽  
Good Evidence ◽  
Regional Variations ◽  
Initial Symptoms ◽  
Cancer Plan ◽  
The Uk

Head and neck cancer affects approximately 8–15 per 100,000 of the UK population, with marked regional variations. There is good evidence that early detection improves prognosis but unfortunately many of the initial symptoms are often non-specific. In 2000 the NHS Cancer Plan introduced the 'two-week wait'(2WW) rule to increase the speed with which patients with suspected cancer are seen by a specialist.

600 Utilisation of radiotherapy in Norway after the implementation of the National cancer plan a prospective, national registry-based study

2015 ◽  
Vol 51 ◽  
pp. S116
Author(s):  
L.M. Asli ◽  
S.O. Kvaløy ◽  
V. Jetne ◽  
T.A. Myklebust ◽  
S.G. Levernes ◽  
...  
Keyword(s):  
National Registry ◽  
National Cancer Plan ◽  
Cancer Plan

P1 Swiss Oncology Nursing agenda: development and contribution to the National Cancer Plan 2010–2015

2010 ◽  
Vol 14 ◽  
pp. S20-S21
Author(s):  
M. Eicher ◽  
I. Bachmann-Mettler ◽  
F. Mathis-Jäggi ◽  
E. Rieder ◽  
M. Shaha
Keyword(s):  
Oncology Nursing ◽  
National Cancer Plan ◽  
Cancer Plan

Achieving national cancer governance reform: Lessons from a successful academic, clinical, and community advocacy approach in New Zealand.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e14131-e14131
Author(s):  
Christopher G. C. A. Jackson ◽  
Diana Sarfati
Keyword(s):  
New Zealand ◽  
Cancer Survival ◽  
Cancer Control ◽  
Direct Result ◽  
Governance Reform ◽  
National Cancer Plan ◽  
Cancer Plan ◽  
The Government ◽  
Cancer Networks ◽  
National Director

e14131 Background: Cancer survival in New Zealand (NZ) is high in global terms but gains in outcome are less than in comparable countries over recent time cohorts. Outcomes of indigenous Māori New Zealanders are significantly worse for most major cancers. This is potentially due to decentralisation of cancer provision and lack of emphasis on national governance. Methods: In 2017, academics, clinicians and patient advocates embarked on a planned and sustained programme of advocacy with the goal of establishing a national cancer plan, centralised cancer governance, and publicly reportable cancer outcomes and quality indicators by region and ethnicity. Elements central to success were partnerships with politicians and opposition parties, building credible media voices, establishing international academic collaborations, clear problem identification, positive evidence-based policy solutions, sustained and consistent yet varied media messaging, and strong relatable patient stories with direct citizen engagement. Results: As a direct result, in 2019 the Government established a National Cancer Agency, updated the national cancer plan for the first time in 16 years, moved to dissolve regional cancer networks, and appointed a national director of cancer control. New funding specifically for cancer investment was also announced and commitments to additional funding have been made. We review the strategies that were most successful, challenges encountered, and outcomes achieved. Conclusions: Advocacy and collaboration between patients, academics and clinicians remains a powerful stimulus for meaningful policy change. Our approach can be instructive for other countries where national cancer control and governmental leadership are faltering.

scholarly journals Can the National Health Service Cancer Plan time-line be applied to colorectal hepatic metastases?

2010 ◽  
Vol 92 (2) ◽  
pp. 136-138
Author(s):  
Claire Jones ◽  
Stephen A Badger ◽  
Jane McClements ◽  
Lloyd McKie ◽  
Tom Diamond ◽  
...  
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Liver Metastases ◽  
National Health ◽  
Colorectal Liver Metastases ◽  
Hepatic Metastases ◽  
Primary Malignancy ◽  
Cancer Plan ◽  
The Uk ◽  
Colorectal Cancer Patients

INTRODUCTION The National Health Service (NHS) Cancer Plan guidelines recommend a maximum 2-week wait from referral to first appointment, and 2 months from referral to treatment for primary cancers. However, there are currently no guidelines available for metastatic disease. In the UK, nearly half of all colorectal cancer patients develop hepatic metastases. Timely, surgical resection offers the potential for cure. The aim of this study was to audit current practice for colorectal liver metastases in a regional hepatobiliary unit, and compare this to the NHS Cancer Plan standards for primary disease. PATIENTS AND METHODS A retrospective review of the unit's database was performed for all hepatic metastases referrals from January 2006 to December 2008. The dates of referral, first appointment, investigations and initiation of treatment, along with patient's age and sex, were recorded on Microsoft Excel and analysed. Time was expressed as mean ± SD in days. RESULTS A total of 102 patients with hepatic metastases were identified. Five were excluded due to incomplete data. The average time from referral to first appointment was 10.6 ± 9.4 days and the average time from referral to treatment was 38.5 ± 28.6 days. Seventy-five (72.7%) had surgical intervention, of whom 37 also had chemotherapy. CONCLUSIONS The data compare favourably to the NHS Cancer Plan guidelines for primary malignancy, demonstrating that a regional hepatobiliary unit is capable of delivering a service for colorectal liver metastases that adheres to the NHS Cancer Plan. Therefore, the NHS Cancer Plan can be applied to this cohort.

Sign in / Sign up

Export Citation Format

Share Document